{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:16:49Z","timestamp":1791908209814,"version":"4.3.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["GM21700"],"award-info":[{"award-number":["GM21700"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DK58127"],"award-info":[{"award-number":["DK58127"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100011781","name":"Shriners Hospitals for Children","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011781","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.bbrc.2009.12.094","type":"journal-article","created":{"date-parts":[[2009,12,24]],"date-time":"2009-12-24T04:10:25Z","timestamp":1261627825000},"page":"1459-1464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Farnesyltransferase inhibitor improved survival following endotoxin challenge in mice"],"prefix":"10.1016","volume":"391","author":[{"given":"Shohei","family":"Shinozaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Fukaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"Ming-Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Fischman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Tompkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Kaneki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2009.12.094_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1001\/jama.1995.03520260039030","article-title":"The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study","volume":"273","author":"Rangel-Frausto","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.bbrc.2009.12.094_bib2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/bja\/aem406","article-title":"Statins and sepsis","volume":"100","author":"Gao","year":"2008","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.bbrc.2009.12.094_bib3","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/hq1101.098486","article-title":"Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors","volume":"21","author":"Takemoto","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2009.12.094_bib4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/153857440303700501","article-title":"Noncholesterol-lowering effects of statins","volume":"37","author":"Pierre-Paul","year":"2003","journal-title":"Vasc. Endovasc. Surg."},{"key":"10.1016\/j.bbrc.2009.12.094_bib5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1568-9972(03)00049-1","article-title":"Atherosclerosis: anti-inflammatory and immunomodulatory activities of statins","volume":"2","author":"Kwak","year":"2003","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bbrc.2009.12.094_bib6","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1161\/01.HYP.37.6.1450","article-title":"HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species","volume":"37","author":"Wassmann","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.bbrc.2009.12.094_bib7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2125.2002.01677.x","article-title":"Direct in vivo evidence of a vascular statin: a single dose of cerivastatin rapidly increases vascular endothelial responsiveness in healthy normocholesterolaemic subjects","volume":"54","author":"Omori","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbrc.2009.12.094_bib8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0735-1097(00)00743-9","article-title":"Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: a double-blind study","volume":"36","author":"Mullen","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbrc.2009.12.094_bib9","first-page":"e149","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"24","author":"Grundy","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2009.12.094_bib10","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/01.CIR.0000086460.55494.AF","article-title":"Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin","volume":"108","author":"Kleemann","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2009.12.094_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0021-9150(00)00597-9","article-title":"A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects\u2014the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action","volume":"155","author":"Sumi","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2009.12.094_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1592\/phco.27.1.20","article-title":"Effectiveness of statins in reducing the rate of severe sepsis: a retrospective evaluation","volume":"27","author":"Martin","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bbrc.2009.12.094_bib13","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/thx.2006.062885","article-title":"Statin treatment and reduced risk of pneumonia in patients with diabetes","volume":"61","author":"van de Garde","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.bbrc.2009.12.094_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1465-9921-6-82","article-title":"The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia","volume":"6","author":"Mortensen","year":"2005","journal-title":"Respir. Res."},{"key":"10.1016\/j.bbrc.2009.12.094_bib15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(06)68041-0","article-title":"Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis","volume":"367","author":"Hackam","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.bbrc.2009.12.094_bib16","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/01.CIR.0000138932.17956.F1","article-title":"Prior statin therapy is associated with a decreased rate of severe sepsis","volume":"110","author":"Almog","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2009.12.094_bib17","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/jac\/dkn019","article-title":"Statins for infection and sepsis: a systematic review of the clinical evidence","volume":"61","author":"Falagas","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbrc.2009.12.094_bib18","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0022-3565(24)39169-4","article-title":"Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis","volume":"294","author":"Ando","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbrc.2009.12.094_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/sur.2006.077","article-title":"Statin (cerivastatin) protects mice against sepsis-related death via reduced proinflammatory cytokines and enhanced bacterial clearance","volume":"9","author":"Chaudhry","year":"2008","journal-title":"Surg. Infect. (Larchmt)"},{"key":"10.1016\/j.bbrc.2009.12.094_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/CIRCULATIONAHA.104.502195","article-title":"Statin treatment after onset of sepsis in a murine model improves survival","volume":"112","author":"Merx","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2009.12.094_bib21","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1161\/01.CIR.0000129774.09737.5B","article-title":"HMG-CoA reductase inhibitor simvastatin profoundly improves survival in a murine model of sepsis","volume":"109","author":"Merx","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2009.12.094_bib22","doi-asserted-by":"crossref","first-page":"F1408","DOI":"10.1152\/ajprenal.00304.2005","article-title":"Inhibition of Ras\/ERK1\/2 signaling protects against postischemic renal injury","volume":"290","author":"Sabbatini","year":"2006","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.bbrc.2009.12.094_bib23","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1111\/j.1460-9568.2007.05935.x","article-title":"Farnesyl transferase inhibitors induce neuroprotection by inhibiting Ha-Ras signalling pathway","volume":"26","author":"Ruocco","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bbrc.2009.12.094_bib24","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/01.WCB.0000067704.86573.83","article-title":"The Ras inhibitor S-trans, trans-farnesylthiosalicylic acid exerts long-lasting neuroprotection in a mouse closed head injury model","volume":"23","author":"Shohami","year":"2003","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbrc.2009.12.094_bib25","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/S0022-2275(20)35355-4","article-title":"Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters","volume":"34","author":"Feingold","year":"1993","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2009.12.094_bib26","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0022-2275(20)39734-0","article-title":"Discordant regulation of proteins of cholesterol metabolism during the acute phase response","volume":"36","author":"Feingold","year":"1995","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2009.12.094_bib27","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/S0022-2275(20)37180-7","article-title":"Endotoxin, tumor necrosis factor, and interleukin-1 decrease hepatic squalene synthase activity, protein, and mRNA levels in Syrian hamsters","volume":"38","author":"Memon","year":"1997","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbrc.2009.12.094_bib28","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1046\/j.1471-4159.2000.0742288.x","article-title":"Expression of a dominant-negative mutant of p21(ras) inhibits induction of nitric oxide synthase and activation of nuclear factor-kappaB in primary astrocytes","volume":"74","author":"Pahan","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2009.12.094_bib29","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/ATVBAHA.107.140673","article-title":"Farnesyltransferase inhibitor, manumycin A, prevents atherosclerosis development and reduces oxidative stress in apolipoprotein E-deficient mice","volume":"27","author":"Sugita","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2009.12.094_bib30","doi-asserted-by":"crossref","first-page":"14203","DOI":"10.1074\/jbc.M411226200","article-title":"Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells","volume":"280","author":"Sugita","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2009.12.094_bib31","doi-asserted-by":"crossref","first-page":"7511","DOI":"10.1074\/jbc.M411871200","article-title":"S-nitrosylation-dependent inactivation of Akt\/protein kinase B in insulin resistance","volume":"280","author":"Yasukawa","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2009.12.094_bib32","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1007\/s10620-007-9994-y","article-title":"A role of cell apoptosis in lipopolysaccharide (LPS)-induced nonlethal liver injury in D-galactosamine (D-GalN)-sensitized rats","volume":"53","author":"Liu","year":"2008","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbrc.2009.12.094_bib33","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.4049\/jimmunol.160.7.3480","article-title":"Activation of caspase 3 (CPP32)-like proteases is essential for TNF-alpha-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model","volume":"160","author":"Jaeschke","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2009.12.094_bib34","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1182\/blood-2008-09-178038","article-title":"Caspase-7 deficiency protects from endotoxin-induced lymphocyte apoptosis and improves survival","volume":"113","author":"Lamkanfi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2009.12.094_bib35","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.lfs.2006.12.034","article-title":"An inhibitor of c-Jun NH2-terminal kinase, SP600125, protects mice from D-galactosamine\/lipopolysaccharide-induced hepatic failure by modulating BH3-only proteins","volume":"80","author":"Takamura","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2009.12.094_bib36","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jhep.2006.08.004","article-title":"The role of JNK2 in toxic liver injury","volume":"45","author":"Liedtke","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrc.2009.12.094_bib37","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jhep.2004.12.036","article-title":"Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats","volume":"42","author":"Jeschke","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbrc.2009.12.094_bib38","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/CCM.0b013e31819b8371","article-title":"Therapeutic effects of erythropoietin in murine models of endotoxin shock","volume":"37","author":"Aoshiba","year":"2009","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbrc.2009.12.094_bib39","doi-asserted-by":"crossref","first-page":"G1124","DOI":"10.1152\/ajpgi.00325.2007","article-title":"Early growth response-1 contributes to galactosamine\/lipopolysaccharide-induced acute liver injury in mice","volume":"293","author":"Pritchard","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbrc.2009.12.094_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.tox.2007.04.021","article-title":"Melatonin attenuates lipopolysaccharide (LPS)-induced apoptotic liver damage in D-galactosamine-sensitized mice","volume":"237","author":"Wang","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.bbrc.2009.12.094_bib41","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/01.shk.0000126648.58732.8c","article-title":"Increased lymphoid tissue apoptosis in baboons with bacteremic shock","volume":"21","author":"Efron","year":"2004","journal-title":"Shock"},{"key":"10.1016\/j.bbrc.2009.12.094_bib42","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00024382-199912000-00001","article-title":"Endotoxin, sepsis, and the primrose path","volume":"12","author":"O\u2019Reilly","year":"1999","journal-title":"Shock"},{"key":"10.1016\/j.bbrc.2009.12.094_bib43","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJM199606273342603","article-title":"Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group","volume":"334","author":"Fisher","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2009.12.094_bib44","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00003246-199707000-00001","article-title":"Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment","volume":"25","author":"Zeni","year":"1997","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbrc.2009.12.094_bib45","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nri1943","article-title":"Apoptosis and caspases regulate death and inflammation in sepsis","volume":"6","author":"Hotchkiss","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2009.12.094_bib46","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/00003246-199907000-00002","article-title":"Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction","volume":"27","author":"Hotchkiss","year":"1999","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbrc.2009.12.094_bib47","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.4049\/jimmunol.174.6.3765","article-title":"Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure","volume":"174","author":"Felmet","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2009.12.094_bib48","doi-asserted-by":"crossref","first-page":"6952","DOI":"10.4049\/jimmunol.166.11.6952","article-title":"Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans","volume":"166","author":"Hotchkiss","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2009.12.094_bib49","first-page":"F51","article-title":"Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras?","volume":"1333","author":"Cox","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2009.12.094_bib50","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/MOL.0b013e3283168ecd","article-title":"Effects of ubiquinone (coenzyme Q10) on myopathy in statin users","volume":"19","author":"Schaars","year":"2008","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.bbrc.2009.12.094_bib51","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1096\/fj.08-128843","article-title":"Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect","volume":"9","author":"Cao","year":"2009","journal-title":"FASEB J."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X0902467X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X0902467X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T10:45:47Z","timestamp":1757760347000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X0902467X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0006291X0902467X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2009.12.094","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Farnesyltransferase inhibitor improved survival following endotoxin challenge in mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2009.12.094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}